Bayer Sues Glenmark Over Patent for Rosacea Drug Finacea

A unit of Bayer AG, Germany’s largest drugmaker, sued India’s Glenmark Generics Ltd. seeking to stop sales of a generic form of its Finacea gel used to treat rosacea.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.